血管紧张素转换酶(ACE)抑制剂是否有利于改变缺血性冠状动脉疾病(冠心病)的病程是一个很重要的问题,然而目前仍然是一个无法回答的问题,其主要原因为近几年来—些小的较短期的临床研究得出了一些不同的结果。在去年11月份美国心脏病协会年会上,从事第二次北斯堪地那维亚关于苯酯丙脯酸(?)Enalapril)对生存影响合作研究(CONSENSUSⅡ, Whether angiotensin converting enzyme (ACE) inhibitors are beneficial for altering the course of ischemic coronary artery disease (CHD) is a very important issue, but it is still an unanswerable question, mainly due to the fact that in recent years - Some minor shorter-term clinical studies have yielded some different results. At the annual meeting of the American Heart Association in November last year, the Second North Scandinavian Cooperative Study on the Survival Effect of Enalapril (CONSENSUS II,